Avalon GloboCare Provides First Quarter 2018 Business Update; Reports 365% Increase in Revenues and Progress Towards Commercialization of its Cell-Based Technologies May 14, 2018
Avalon GloboCare Forms Joint Laboratory with Top-Ranked Hospital in Shanghai for Regenerative Exosomics Apr 24, 2018
Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative in Stem Cell Technology and Regenerative Medicine Feb 28, 2018
Avalon GloboCare Forms Strategic Partnership with Major Biomedical Enterprise Da An Gene Jan 30, 2018
Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the "China's Impact on The World of Regenerative Medicine" Session at the 13th Annual World Stem Cell Summit Jan 21, 2018
Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions to Accelerate Growth Jan 16, 2018
